Barclays’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $66.7K | Sell |
500
-20,100
| -98% | -$3.2M | ﹤0.01% | 4198 |
|
|
2025
Q4 | $3.57M | Buy |
+20,600
| New | +$3.39M | ﹤0.01% | 2482 |
|
|
2020
Q4 | – | Sell |
-1,800
| Closed | -$329K | – | 5083 |
|
|
2020
Q3 | $329K | Hold |
1,800
| – | – | ﹤0.01% | 3522 |
|
|
2020
Q2 | $320K | Sell |
1,800
-15,300
| -89% | -$2.61M | ﹤0.01% | 3694 |
|
|
2020
Q1 | $2.39M | Buy |
17,100
+4,400
| +35% | +$589K | ﹤0.01% | 2129 |
|
|
2019
Q4 | $1.72M | Sell |
12,700
-266,300
| -95% | -$33.5M | ﹤0.01% | 3162 |
|
|
2019
Q3 | $30.6M | Sell |
279,000
-331,600
| -54% | -$43M | 0.02% | 662 |
|
|
2019
Q2 | $87.4M | Buy |
610,600
+608,600
| +30,430% | +$83.4M | 0.05% | 303 |
|
|
2019
Q1 | $284K | Sell |
2,000
-700
| -26% | -$94.7K | ﹤0.01% | 4560 |
|
|
2018
Q4 | $314K | Buy |
2,700
+2,600
| +2,600% | +$341K | ﹤0.01% | 4243 |
|
|
2018
Q3 | $15K | Sell |
100
-900
| -90% | -$115K | ﹤0.01% | 6546 |
|
|
2018
Q2 | $98K | Sell |
1,000
-2,100
| -68% | -$183K | ﹤0.01% | 5259 |
|
|
2018
Q1 | $252K | Buy |
3,100
+2,800
| +933% | +$225K | ﹤0.01% | 4631 |
|
|
2017
Q4 | $23K | Sell |
300
-30,500
| -99% | -$2.2M | ﹤0.01% | 6230 |
|
|
2017
Q3 | $2.12M | Buy |
30,800
+25,200
| +450% | +$1.64M | ﹤0.01% | 2291 |
|
|
2017
Q2 | $387K | Buy |
5,600
+3,200
| +133% | +$196K | ﹤0.01% | 3761 |
|
|
2017
Q1 | $109K | Sell |
2,400
-1,700
| -41% | -$89K | ﹤0.01% | 4818 |
|
|
2016
Q4 | $222K | Buy |
4,100
+3,900
| +1,950% | +$213K | ﹤0.01% | 4140 |
|
|
2016
Q3 | $12K | Sell |
200
-2,400
| -92% | -$132K | ﹤0.01% | 5710 |
|
|
2016
Q2 | $130K | Buy |
2,600
+1,000
| +63% | +$53.4K | ﹤0.01% | 4225 |
|
|
2016
Q1 | $102K | Sell |
1,600
-4,100
| -72% | -$243K | ﹤0.01% | 4347 |
|
|
2015
Q4 | $342K | Sell |
5,700
-8,600
| -60% | -$542K | ﹤0.01% | 3499 |
|
|
2015
Q3 | $972K | Sell |
14,300
-3,400
| -19% | -$252K | ﹤0.01% | 2737 |
|
|
2015
Q2 | $1.24M | Buy |
17,700
+12,000
| +211% | +$803K | ﹤0.01% | 2690 |
|
|
2015
Q1 | $382K | Buy |
5,700
+4,000
| +235% | +$231K | ﹤0.01% | 3846 |
|
|
2014
Q4 | $90K | Sell |
1,700
-2,500
| -60% | -$121K | ﹤0.01% | 5291 |
|
|
2014
Q3 | $176K | Buy |
4,200
+3,400
| +425% | +$150K | ﹤0.01% | 4854 |
|
|
2014
Q2 | $35K | Sell |
800
-12,700
| -94% | -$515K | ﹤0.01% | 6180 |
|
|
2014
Q1 | $500K | Buy |
13,500
+5,200
| +63% | +$192K | ﹤0.01% | 3958 |
|
|
2013
Q4 | $282K | Buy |
8,300
+7,000
| +538% | +$236K | ﹤0.01% | 4656 |
|
|
2013
Q3 | $46K | Sell |
1,300
-11,900
| -90% | -$439K | ﹤0.01% | 6102 |
|
|
2013
Q2 | $491K | Buy |
+13,200
| New | +$466K | ﹤0.01% | 4219 |
|
Other funds holding MOH
VPM
VCM
Barclays's MOH Position: Q1 2026 in Review
Barclays increased its Molina Healthcare (MOH) stake by 0.45% in Q1 2026, buying an estimated $161K and bringing the position to 227,443 shares worth $30.3M. The position accounts for 0.01% of the portfolio, ranked #929.
Barclays first reported a position in MOH in Q2 2013 and has held it in 52 quarters since. The position peaked at $70.8M in Q1 2024. 523 funds tracked by Wall St. Rank hold MOH as of Q1 2026.
- Barclays held 227,443 shares of Molina Healthcare worth $30.3M as of Q1 2026.
- Barclays bought 1,013 Molina Healthcare shares in Q1 2026, an estimated $161K.
- Molina Healthcare made up 0.01% of Barclays's portfolio in Q1 2026, its #929 holding.
- Barclays first reported a position in Molina Healthcare in Q2 2013 and has held it in 52 quarters since.
- Barclays's Molina Healthcare position peaked at $70.8M in Q1 2024.
- 523 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.